Rachel Flynn, MED assistant professor of pharmacology and experimental therapeutics, was one of the recipients. Ms. Flynn has a doctoral degree in cancer biology and will use her stipend to hire lab personnel and reagents. She studies telomeres in cancer development.
“So far, Flynn has seen promising results. One compound she’s testing in vitro doesn’t just stop cancer cells from growing, but completely obliterates them—and with minimal effects to surrounding healthy cells. The next step is to test the compound in mouse models.
“If it works as well as it does in a dish, it’ll be amazing,” she says.” – Boston University